Horsham, United Kingdom

Harinder Pal Singh

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2012.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Harinder Pal Singh: Innovator in Pharmaceutical Chemistry

Introduction

Harinder Pal Singh is a notable inventor based in Horsham, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the body. His work is essential for advancing treatments for various medical conditions.

Latest Patents

Singh holds a patent for "Purine derivatives for use as adenosine A-2A receptor agonists." This patent describes compounds of formula I in free or salt form, wherein R, R, and R have specific meanings as indicated in the specification. These compounds are particularly useful for treating conditions mediated by the activation of the adenosine A receptor, especially inflammatory or obstructive airways diseases. The patent also details pharmaceutical compositions that contain these compounds and a process for preparing them.

Career Highlights

Harinder Pal Singh is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions in drug development. Singh's expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Singh has collaborated with esteemed colleagues, including Robin Alec Fairhurst and Roger John Taylor. These collaborations have fostered an environment of innovation and have contributed to the advancement of pharmaceutical research.

Conclusion

Harinder Pal Singh's contributions to pharmaceutical chemistry and his innovative patent work highlight his importance in the field. His dedication to developing effective treatments for medical conditions showcases the impact of his research on healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…